Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04580940 · ClinicalTrials.gov registry record
SpyGlass™ Discover Percutaneous
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 50
- Enrollment target
NCT04580940 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 50 participants.
The verdict
NCT04580940 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To document the clinical utility of percutaneous cholangiopancreatoscopy using a thin, disposable, flexible endoscope for evaluation and treatment of complex pancreaticobiliary disease in a prospective, multi-center case series
Interventions
- DEVICE SpyGlass™ Discover Digital System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2023-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04580940
The ClinicalTrials.gov registry entry for NCT04580940 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpyGlass™ Discover Digital System is the first listed.
NCT04580940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04580940 about?
NCT04580940 is a clinical study titled "SpyGlass™ Discover Percutaneous". To document the clinical utility of percutaneous cholangiopancreatoscopy using a thin, disposable, flexible endoscope for evaluation and treatment of complex pancreaticobiliary disease in a prospective, multi-center case series
What is the current status of trial NCT04580940?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-07-27. Estimated completion is 2023-01-14.
What interventions are being tested in trial NCT04580940?
The interventions under investigation include: SpyGlass™ Discover Digital System (DEVICE).
Who is sponsoring clinical trial NCT04580940?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.